A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

NCT01311180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: Sensoril®
DRUG: Placebo

Sponsor

Natreon, Inc.